Xyall
ID: 17662330Xyall is a platform specializing in molecular pathology solutions worldwide founded in 2018 by Guido du Pree.
3
Funding Rounds
$20.9m
Money raised
Recent Funding Rounds
Overview
Xyall is a platform specializing in molecular pathology solutions worldwide founded in 2018 by Guido du Pree.
- Website:
- Business model: B2B
- Headquarters: Eindhoven
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Gu*** du Pr** |
|
- | |
| Ha** va* Wi********* |
|
- |
Funding
Funding series
Funding Series Analysis
The company Xyall has raised a total of $14.6m in funding over 3 rounds.
Key Insights:
- Xyall Venture Round, February 2026: $9m
- Xyall January 2020 Series B Funding Round: $5.6m
- Xyall 2022 Series B Funding Round: $6.3m
Industries
Xyall is active in the following industries: